Butler Hospital is a private, non-profit, psychiatric and substance abuse hospital for adolescents, adults, and seniors, located at 345 Blackstone Boulevard in Providence, Rhode Island.

During the past decade, Butler Hospital conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 44 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 25 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Butler Hospital" #1 sponsor was "Butler Hospital" with 72 trials, followed by "Brown University" with 9 trials sponsored, "Pfizer" with 7 trials sponsored, "Biogen" with 5 trials sponsored and "Eli Lilly and Company" with 5 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Butler Hospital" #1 collaborator was "National Institute of Mental Health (NIMH)" with 16 trials as a collaborator, "Brown University" with 8 trials as a collaborator, "Butler Hospital" with 8 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 8 trials as a collaborator and "National Institute on Aging (NIA)" with 6 trials as a collaborator. Other collaborators include 72 different institutions and companies that were collaborators in the rest 49 trials.

According to Clinical.Site data, the most researched conditions in "Butler Hospital" are "Alzheimer's Disease" (24 trials), "Depression" (22 trials), "Alzheimer Disease" (10 trials), "Suicide" (9 trials) and "Major Depressive Disorder" (7 trials). Many other conditions were trialed in "Butler Hospital" in a lesser frequency.

Most popular intervention types in "Butler Hospital" are "Behavioral" (56 trials), "Drug" (52 trials), "Device" (18 trials), "Other" (17 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Health Education" (6 trials), "Solanezumab" (5 trials), "Gantenerumab" (4 trials) and "Mobile Application to Prevent Suicide (MAPS)" (4 trials). Other intervention names were less common.

The vast majority of trials in "Butler Hospital" are 126 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 29 active trials in "Butler Hospital". 4 are not yet recruiting, 18 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 87 completed trials in Butler Hospital, 1 suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Butler Hospital, 3 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 65 trials that are defined as “Not Applicable".

Butler Hospital has several departments that took part in Clinical trials: "Butler Hospital Memory and Aging Program" - 13 trials